Extends and expands several Medicare telehealth flexibilities through late 2027, adds billing and documentation rules for hospice telehealth encounters, and requires new studies and reports on hospital-at-home selection/outcomes and lab-test fraud risks. It also creates a new DME billing review authority starting in 2028, directs HHS to issue telehealth guidance for people with limited English proficiency, adjusts in‑home cardiopulmonary rehabilitation rules, and temporarily allows virtual-only suppliers to offer the Medicare Diabetes Prevention Program (MDPP) from 2026–2030.

Overall, the bill mixes near-term access and program-flexibility changes for beneficiaries and providers with fraud-control and administrative actions (studies, reports, prepayment review authority, and guidance) intended to protect Medicare funds and clarify program operations.